A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT) - Teal, Philip; Hacke, Werner; Hennerici, Michael G. (Stroke, 2009)
Gesehen am 21.11.2014